Dublin, Oct. 14, 2013 (GLOBE NEWSWIRE) -- Research and Markets (http://www.researchandmarkets.com/research/bq6p7v/bioinformatics)
has announced the addition of the "Global
Bioinformatics Market Report 2013-2017" report to their
offering.
Based on the use of bioinformatics, the various sectors covered in
this report are medicine, agriculture, environment, animal,
forensic, academics, and others (homeland security and defense,
law-enforcement groups, bio-weapon creation, antibiotic resistance,
and evolutionary biotechnology). The medical sector accounted for a
lions share of the bioinformatics market in 2012. The medical
sector has been further classified as molecular medicine, gene
therapy, drug discovery and development, clinical diagnostics, and
reproductive biotechnology.
The bioinformatics
market, by products and services, has been classified as knowledge
management tools, platforms, and services. These segments are
integral components of application areas such genomics, proteomics,
and other life-science research, and are used for the acquisition,
development, management, analysis, and integration of huge amounts
of data generated during biological research. Knowledge management
tools dominated the bioinformatics market in 2012, followed by
platforms and services. Knowledge management tools are majorly used
by researchers to handle large volumes of heterogeneous information
and to integrate them with existing knowledge repositories.
Segments in the bioinformatics application market are genomics,
proteomics, chemoinformatics, molecular phylogenetics,
metabolomics, transcriptomics, and others (glycomics, cytomics,
physiomics and interactomics). Genomics contributes the highest to
the bioinformatics market; it is poised to grow at a high CAGR from
2012 to 2017. The application of bioinformatics in genomics is
driven by growing pharmacogenomics applications for the discovery
of new drugs and characterization of older drugs, development of
new bioinformatics tools to handle large sets of data generated
through genomics research, and decreasing cost of DNA sequencing.
Metabolomics is the fastest-growing application area due to
developments in analytical instruments that enable profiling of
metabolites with high throughput and accuracy.
North America accounted for the largest market share of the
bioinformatics market, followed by Europe, in 2012. This is
attributed by an increasing demand for bioinformatics in genomics
and proteomics research, technological advancements, growing use of
bioinformatics tools in the drug discovery process, and presence of
a large number of market players. However, other regions such as
Asian and Latin American countries represent emerging markets,
owing to a rise in research outsourcing by pharmaceutical giants,
increasing number of Contract Research Organizations (CROs), rise
in public and private sector investment, and growing industry
-academia partnerships.
Key Topics Covered:
1 Introduction
2 Executive Summary
3 Market Overview
4 Global Bioinformatics Market, By Sectors
5 Global Bioinformatics Market, By Products & Services
6 Global Bioinformatics Market, By Applications
7 Geographic Analysis
8 Competitive Landscape
9 Company Profiles
- Accelrys, Inc
- Active Motif, Inc
- Affymetrix, Inc
- Agilent Technologies, Inc
- Biomatters, Ltd
- Biomax Informatics Ag
- Clc Bio
- Geneva Bioinfromatics (Genebio) Sa
- Id Business Solutions Ltd
- Illumina, Inc
- Instem Plc
- Integromics SL
- Kinexus Bioinformatics Corporation
- Knome, Inc
- Life Technologies Corporation
- Nonlinear Dynamics Ltd
- Ocimum Biosolutions, Ltd
- Partek, Incorporated
- Perkinelmer, Inc
- Textco Biosoftware, Inc
For more information visit http://www.researchandmarkets.com/research/bq6p7v/bioinformatics
Research and Markets
Laura Wood, Senior Manager.
press@researchandmarkets.com
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector:
Bioinformatics